Imperial College London

ProfessorCharlotteBevan

Faculty of MedicineDepartment of Surgery & Cancer

Professor of Cancer Biology
 
 
 
//

Contact

 

charlotte.bevan Website

 
 
//

Assistant

 

Mrs Suzy Ford +44 (0)20 7594 2135

 
//

Location

 

139ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Pine:2016:10.12688/f1000research.8019.1,
author = {Pine, AC and Fioretti, FF and Brooke, GN and Bevan, CL},
doi = {10.12688/f1000research.8019.1},
journal = {F1000 Research},
title = {Advances in genetics: widening our understanding of prostate cancer},
url = {http://dx.doi.org/10.12688/f1000research.8019.1},
volume = {5},
year = {2016}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Prostate cancer is a leading cause of cancer-related death in Western men. Our understanding of the genetic alterations associated with disease predisposition, development, progression, and therapy response is rapidly improving, at least in part, owing to the development of next-generation sequencing technologies. Large advances have been made in our understanding of the genetics of prostate cancer through the application of whole-exome sequencing, and this review summarises recent advances in this field and discusses how exome sequencing could be used clinically to promote personalised medicine for prostate cancer patients.
AU - Pine,AC
AU - Fioretti,FF
AU - Brooke,GN
AU - Bevan,CL
DO - 10.12688/f1000research.8019.1
PY - 2016///
SN - 2046-1402
TI - Advances in genetics: widening our understanding of prostate cancer
T2 - F1000 Research
UR - http://dx.doi.org/10.12688/f1000research.8019.1
UR - http://hdl.handle.net/10044/1/37078
VL - 5
ER -